Non-Anti-Neutrophil Anti-Cytoplasmic Antibodies Associated Methimazole-Induced Nephritis: Case and Review of Literature

Hengyi Guo, David Levitt, Kashif M. Munir, Cynthia B. Drachenberg, Rana Malek, Elizabeth M. Lamos

Abstract


Current anti-thyroid therapy is rarely associated with adverse effects such as vasculitis or nephritis. Historically, vasculitis associated with anti-thyroid therapy is associated with anti-neutrophil anti-cytoplasmic antibodies (ANCA). Here, we report a rare case of ANCA-negative interstitial nephritis secondary to methimazole, resulting in end organ renal failure. A 27-year-old male with a history of Graves’ hyperthyroidism on methimazole anti-thyroid therapy presented to the hospital with shortness of breath and chest pain, complicated by a pericardial effusion and acute kidney injury (AKI) requiring emergent hemodialysis. The diagnosis of drug-induced ANCA-negative vasculitis was based on the temporal relationship between clinically evident vasculitis and treatment with methimazole, after excluding other causes of vasculitis. The lack of ANCA-associated positivity should not deter clinicians from considering stopping the offending agent and pursuing more definitive therapy (radioactive iodine or surgery as appropriate).




J Endocrinol Metab. 2018;8(2-3):47-51
doi: https://doi.org/10.14740/jem505w

Keywords


Methimazole; Interstitial nephritis; Renal failure; ANCA-negative vasculitis

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.